HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Federica Saletta Selected Research

MTOR Inhibitors

4/2014Advances in paediatric cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Federica Saletta Research Topics

Disease

24Neoplasms (Cancer)
07/2023 - 08/2006
5Neuroblastoma
07/2021 - 11/2015
3Neoplasm Metastasis (Metastasis)
07/2023 - 01/2013
3Hypoxia (Hypoxemia)
01/2013 - 03/2010
2Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2021
2Iron Deficiencies
10/2011 - 03/2010
2Chromosomal Instability (Chromosome Stability)
08/2007 - 08/2006
1Disease Progression
01/2022
1Chromosome Aberrations (Chromosome Abnormalities)
07/2021
1Prostatic Neoplasms (Prostate Cancer)
06/2021
1Sarcoma (Soft Tissue Sarcoma)
01/2021
1Ewing Sarcoma (Sarcoma, Ewing)
01/2021
1Hepatoblastoma
11/2020
1Friedreich Ataxia (Friedreich's Ataxia)
12/2012
1Lung Neoplasms (Lung Cancer)
01/2009
1Carcinoma (Carcinomatosis)
05/2007
1Urinary Bladder Neoplasms (Bladder Cancer)
05/2007
1Carcinogenesis
05/2007
1Xeroderma Pigmentosum (Kaposi's Disease)
08/2006

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
01/2023 - 05/2007
6Proteins (Proteins, Gene)FDA Link
10/2020 - 08/2006
5IronIBA
01/2013 - 03/2010
4CopperIBA
07/2023 - 01/2018
4Chelating AgentsIBA
07/2023 - 03/2010
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2006
4Messenger RNA (mRNA)IBA
01/2022 - 12/2010
2RNA (Ribonucleic Acid)IBA
01/2023 - 10/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 06/2021
2Dextrans (Dextran)FDA Link
06/2021 - 01/2018
2B7-H1 AntigenIBA
10/2020 - 11/2017
2Copper Transporter 1IBA
10/2020 - 01/2018
2Codon (Codons)IBA
01/2009 - 08/2006
24-biphenylamineIBA
08/2007 - 05/2007
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1Methotrexate (Mexate)FDA LinkGeneric
01/2022
1Genetic Markers (Genetic Marker)IBA
01/2022
1Cell-Free Nucleic AcidsIBA
07/2021
1Circulating Tumor DNAIBA
07/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2021
1CurcuminIBA
06/2021
1Chimeric Antigen ReceptorsIBA
01/2021
1AntigensIBA
01/2021
1ErythropoietinFDA Link
01/2021
1MetalsIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021
1CateninsIBA
11/2020
1Blocking AntibodiesIBA
10/2020
1Death Domain ReceptorsIBA
10/2020
1CarbonIBA
04/2020
1Catechin (Z 7300)IBA
01/2018
1cupric chloride (copper(II) chloride)FDA Link
01/2018
1Glutathione (Reduced Glutathione)IBA
01/2018
1Irinotecan (Camptosar)FDA LinkGeneric
01/2017
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2017
1ChromatinIBA
11/2015
1CBLC137IBA
11/2015
1Histone ChaperonesIBA
11/2015
1tipifarnib (R115777)IBA
04/2014
1Bortezomib (Velcade)FDA Link
04/2014
1MTOR InhibitorsIBA
04/2014
1VorinostatFDA Link
04/2014
1Sorafenib (BAY 43-9006)FDA Link
04/2014
1Bevacizumab (Avastin)FDA Link
04/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2014
1Cyclin-Dependent Kinase Inhibitor p27IBA
01/2013
1TunicamycinIBA
01/2013
1Eukaryotic Initiation Factor-3IBA
12/2010
1Peptide Initiation Factors (Initiation Factor)IBA
12/2010
1Transcription Factors (Transcription Factor)IBA
03/2010
1SmokeIBA
08/2007
1Methylnitronitrosoguanidine (MNNG)IBA
08/2007
1AminesIBA
05/2007
1DNA AdductsIBA
05/2007
1CarcinogensIBA
08/2006

Therapy/Procedure

9Therapeutics
01/2022 - 12/2011
2Precision Medicine
01/2022 - 01/2018
2Drug Therapy (Chemotherapy)
11/2015 - 04/2014
1Chelation Therapy (Therapy, Chelation)
07/2023
1Immunotherapy
01/2023
1Heterologous Transplantation (Xenotransplantation)
01/2022
1Adjuvant Chemotherapy
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021